HIGHLIGHTS
- who: Ruozhu Dai from the Leiden University, Netherlands Harokopio University, Greece have published the article: CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease, in the Journal: (JOURNAL)
- what: TZ wrote the manuscript.
- how: All methods in this study were carried out in accordance with the Declaration of Helsinki. These results indicated that men were the CAD high-risk population mainly due to their unhealthy habits of drinking and smoking. These results indicated that a substantial portion of patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.